Alarm Fatigue in the ICU—A Huge Problem Made Worse by COVID-19
Can AI revolutionize the growing, billion-dollar global market for clinical alarm management in hospitals—and help save lives?
AI Breathes New Life into Old Drugs
Deep learning uncovers the potential of existing medications to target different diseases.
Is Your DNA Data Safe in Blackstone’s Hands?
The Wall Street giant’s big bet on Ancestry.com drives home the financial realities facing the consumer genomic revolution.
Hacking the Skin Microbiome to Fool Mosquitos and Prevent Malaria
Long-lasting, bacteria-based repellent is the goal of DARPA project aiming to protect U.S. soldiers overseas.
To Boldly Go Where No Pharma Has Gone Before
Astropharmacies could grow drugs on demand for future space travelers.
Predictions for 2021: Welcome to the New Uncertainty
This could be a “hinge year” in history: the opportunity to grasp a new and improved future for ourselves, our children, and our planet—or not.
The Focus of His Energy
Neal Kassell is on a mission to bring focused ultrasound therapy to the masses.
Inside the Movement to Decolonize Psychedelic Pharma
As Western medicine brings psychedelics into mainstream use, a growing movement is innovating new business models grounded in reciprocity and inclusion.
Sniffing Out Diseases
A telltale COVID-19 symptom underscores the scientific significance of smell—for both patients and practitioners.
After the Madness—Pandemic Silver Linings in Bioscience
Will the frenzied rush to understand and treat SARS-CoV-2 bring longer lasting benefit to the world of scientific research and medicine?
There Might Be a Better Time to Pop That Pill
Syncing cures with circadian rhythms is an idea whose moment has finally come.
Inside the Race to Build Life From Scratch
Synthetic biologists aim to transform the world with manmade organisms. What will it take to get there?
Designer Babies Are Here. What’s the Next Edit?
A Chinese scientist engineered kids to resist HIV. Here are other changes that could be on the feature list for Humanity 2.0.